As leading experts in the field of regenerative rehabilitation, IMAC Regeneration feels it necessary to contribute to the conversation surrounding regenerative and cellular treatments. The IMAC Nation podcast features IMAC's team including physicians, surgeons, scientists, and athletes as well as guest speakers joining in the discussion of Innovative Medical Advancements and Care. IMAC Nation will use scientific data and therapeutic outcomes to separate fact from generic industry static. We will release a new episode each week and look forward to your feedback.
Click here to download IMAC Nation on your preferred podcast service.
Attachments
Original document
Permalink
Disclaimer
IMAC Holdings Inc. published this content on 29 May 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 June 2020 08:40:09 UTC
IMAC Holdings, Inc. owns and manages health and wellness centers that delivers sports medicine, orthopedic care, and restorative joint and tissue therapies for movement restricting pain and neurodegenerative diseases. The Company provides movement, orthopedic and neurological therapies through its chain of Innovative Medical Advancements and Care (IMAC) Regeneration Centers. The Company, through its outpatient medical clinics, provide conservative, minimally invasive medical treatments to help patients with back pain, knee pain, joint pain, ligament and tendon damage, and other related soft tissue conditions. It operates through two business segments: outpatient medical centers and clinical research division. The Company's research division is conducting a Phase I clinical trial evaluating a mesenchymal stem cell therapy candidate for bradykinesia due to Parkinsonâs disease. The Company operates approximately 10 outpatient medical clinics in five states in the United States.
IMAC HOLDINGS, INC. 
